Surgery Risk Calculator (Revised Cardiac Risk Index)

The Revised Cardiac Risk Index (RCRI), developed by Lee and colleagues at Brigham and Women’s Hospital and published in 1999, is the most widely used tool for estimating the risk of major cardiac complications after non-cardiac surgery. It is recommended in major guidelines including the ACC/AHA (American College of Cardiology / American Heart Association) perioperative cardiac assessment.

The index uses six binary predictors, each worth exactly one point. No weighting, no coefficients. That plainness is the reason it has outlasted more than a quarter-century of fancier models.

1. High-risk surgery: intraperitoneal, intrathoracic, or suprainguinal vascular procedures.
2. History of ischemic heart disease: a prior MI (myocardial infarction, or heart attack), a positive stress test, current angina, use of nitrates, or pathological Q waves on the ECG (electrocardiogram).
3. History of congestive heart failure: prior pulmonary edema, paroxysmal nocturnal dyspnea (waking at night short of breath), bilateral rales, or chest x-ray evidence.
4. History of cerebrovascular disease: a prior stroke or TIA (transient ischemic attack, sometimes called a mini-stroke).
5. Diabetes mellitus requiring insulin therapy. Tablets alone do not count.
6. Preoperative serum creatinine above 2.0 mg/dL (177 micromol/L).

The total, 0 to 6, maps to an estimated risk of a major cardiac event within 30 days of surgery. “Major cardiac event” here means myocardial infarction, pulmonary edema, ventricular fibrillation, primary cardiac arrest, or complete heart block.

Notice where the jump is in Lee’s figures. Going from one factor to two is a sevenfold increase, and it is by far the steepest step on the scale. Two ordinary-sounding boxes ticked is not twice the risk of one.

Lee’s original population was 4,315 patients undergoing major non-cardiac surgery. Later validations have generally confirmed the discrimination at the higher classes. The index works less well in vascular surgery patients, where the intrinsic risk runs higher than the score suggests.

Use this as one input among several. Real perioperative decisions also weigh functional capacity, measured in METs (metabolic equivalents, where 1 MET is resting oxygen use and climbing two flights of stairs is about 4), how urgent the operation is, and the patient’s overall trajectory. The RCRI gives a structured starting point for a conversation, not a verdict.

Limitations worth knowing: it does not capture frailty, anemia, valvular disease severity, or recent stent timing, and drug-eluting stent rules are handled separately.

It is also a 1999 instrument, and its absolute numbers have not aged well. The 2017 Canadian Cardiovascular Society guideline (Duceppe and colleagues) pooled later validation studies, counted deaths as well, and put the 30-day risk of death, heart attack or cardiac arrest at 3.9%, 6.0%, 10.1% and 15.0% for scores of 0, 1, 2 and 3 or more.
Those are well above Lee’s figures, partly because modern studies check troponin routinely and catch heart attacks that once went unnoticed. In them each extra factor multiplies the risk by about one and a half, with no single cliff.
The 2024 AHA/ACC perioperative guideline prints no per-score figures at all and treats any score above 1 as elevated risk. The calculator shows both sets of numbers.